Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Active not recruiting 2Recruiting 1

Sponsor Class

NIH 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3

Conditions

Carcinoma, Non-Small-Cell Lung 8Prostatic Neoplasms 7Glioblastoma 6Squamous Cell Carcinoma of Head and Neck 5Rectal Neoplasms 5Oropharyngeal Neoplasms 5Breast Neoplasms 5Lung Neoplasms 4Burkitt Lymphoma 4Urinary Bladder Neoplasms 3Mouth Neoplasms 3Glioma 3Astrocytoma 3Adenocarcinoma of Lung 3Uterine Cervical Neoplasms 2Rhabdomyosarcoma 2Pancreatic Neoplasms 2Mesothelioma, Malignant 2Medulloblastoma 2Lymphoma, Follicular 2Laryngeal Neoplasms 2Hodgkin Disease 2Esophageal Neoplasms 2Carcinoma, Squamous Cell 2Carcinoma 2Breast Carcinoma In Situ 2Adenocarcinoma, Bronchiolo-Alveolar 2Wilms Tumor 1Vaginal Neoplasms 1Triple Negative Breast Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 13Temozolomide 12Specimen Handling 8X-Rays 7Biopsy 7Nuclear Medicine Department, Hospital 6Radiation 5Phantoms, Imaging 5trametinib 4erdafitinib 4dabrafenib 4ulixertinib 3larotrectinib 3Radiotherapy 3tipifarnib 2selpercatinib 2palbociclib 2olutasidenib 2olaparib 2ivosidenib 2ensartinib 2binimetinib 2Nivolumab 2D2C7-(scdsFv)-PE38KDEL 2vorasidenib 1veliparib 1trastuzumab deruxtecan 1trastuzumab biosimilar HLX02 1tazemetostat 1selinexor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Glioma × Radiotherapy × 30 days × Clear all
NCT05099003 2026-05-29

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

National Cancer Institute (NCI)

Phase 1/2 Recruiting
132 enrolled
CNS

Glioma

NCT03581292 2026-05-27

Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations

National Cancer Institute (NCI)

Phase 2 Active not recruiting
38 enrolled 13 charts
CNS

Astrocytoma, Glioblastoma, Glioma

NCT03919071 2026-05-27

Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma

National Cancer Institute (NCI)

Phase 2 Active not recruiting
58 enrolled
CNS

Astrocytoma, Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡